| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $295K | +2069.3% | — |
| Cost of Revenue | $220K | +3120.7% | — |
| Gross Profit | $75K | +1011.4% | — |
| R&D Expense | $93K | -28.7% | -67.3% |
| SG&A Expense | $18.8M | +1198.3% | +1184.0% |
| Operating Income | -$19.2M | -912.9% | -825.8% |
| Net Income | -$19.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $0 | — | — |
| Inventory | $1.4M | — | — |
| Current Assets | $3.0M | — | — |
| Total Assets | $4.6M | — | — |
| Current Liabilities | $4.4M | — | — |
| Total Liabilities | $12.3M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | — |
| Investing Cash Flow | -$657K | — | — |
| Financing Cash Flow | $5.0M | — | — |
| -792.2% |
| EPS (Basic) | -$0.54 | +26.0% | -575.0% |
| EPS (Diluted) | -$0.54 | +26.0% | -575.0% |
| — |
| Stockholders' Equity | -$7.7M | -25.8% | -230.6% |